The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Neurimmune AG has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca's Rare Disease group, to develop ...
read more
Rain Therapeutics Inc. announced a clinical supply agreement with Roche for the supply of the anti-Programmed Death Ligand-1 (PD-L1) monoclonal ...
read more
Covis Pharma Group announced that Covis Pharma GmbH has completed the acquisition of Eklira® (aclidinium bromide), known as Tudorza® in the US and ...
read more
NRx Pharmaceuticals has submitted an application for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA) for the use of ...
read more
Samsung Bioepis Co., Ltd. and Organon & Co. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental ...
read more
Thursday, January 06, 2022
TRexBio Inc. has entered into a multi-year research collaboration and licensing agreement with Janssen Pharmaceutica NV, one of the Janssen ...
read more
Wednesday, January 05, 2022
Cullinan Oncology announced that the FDA has granted Breakthrough Therapy Designation for CLN-081 for the treatment of patients with locally advanced ...
read more
Wednesday, January 05, 2022
Biogen Inc. and Ionis Pharmaceuticals, Inc. announced that Biogen exercised its option to obtain from Ionis a worldwide, exclusive, royalty-bearing ...
read more
Wednesday, January 05, 2022
ILiAD Biotechnologies, a late stage biotech development company focused on global eradication of disease due to Bordetella pertussis, today announced ...
read more
Wednesday, January 05, 2022
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster...
read more
Tuesday, January 04, 2022
Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced that the company has closed on a $31 million ...
read more
Tuesday, January 04, 2022
Merck and Ridgeback Biotherapeutics announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of ...
read more
Tuesday, January 04, 2022
Takeda Pharmaceutical Company Limited announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)...
read more
Thursday, December 30, 2021
Allarity Therapeutics, Inc. has announced the submission of a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) seeking ...
read more
Wednesday, December 29, 2021
Sandoz has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150 mg, for intravenous use) developed by EirGenix, ...
read more